ACXP vs ROST · $11.3M cap vs P/E 21, rev $21.13B
Acurx Pharmaceuticals LLC (ACXP) versus Ross Stores Inc (ROST) — a side-by-side from cached financials, not a winner call.
Acurx Pharmaceuticals LLC (ACXP) is a biotechnology company listed on US.
Ross Stores Inc (ROST) is a apparel retail company listed on US.
ACXP does not have a complete income-statement cache yet.
Latest reported ROST revenue for 2025-02-01 was $21.13B. Net income was $2.09B. Revenue was up 3.7% from 2024-02-03 to 2025-02-01. ROST currently screens at market cap $43.03B and trailing P/E 20.8.
ACXP currently screens at market cap $11.3M. ROST currently screens at market cap $43.03B and trailing P/E 20.8.
Not investment advice. Open the ACXP and ROST stock pages for the full models.
Not investment advice.